MedTrace Logo

Evaluate the Impact of Drawtex in Venous Leg Ulcers

NCT01319123 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2012-10-30

No results posted yet for this study

Summary

This is a clinical study to comparatively evaluate the impact of Drawtex wound dressing against wound bioburden in moderately to highly exuding venous leg ulcers.

Conditions

  • Moderatley to Highly Exuding Venous Leg Ulcers

Interventions

DEVICE

Drawtex dressing

The dressing is indicated for moderately to heavily exuding wounds such as venous leg ulcers

Sponsors & Collaborators

  • Beier Drawtex Healthcare, (PTY). Ltd

    collaborator UNKNOWN

  • Southwest Regional Wound Care Center

    lead OTHER

Principal Investigators

  • Randall D Wolcott, M.D. · Southwest Regional Wound Care

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01319123 on ClinicalTrials.gov